Research To Practice | Oncology Videos

Latest Episodes:

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management (Companion Faculty Lecture) Jul 28, 2025

Show notes

Featuring a slide presentation and related discussion from Dr Hope S Rugo, including the following topics:

Current treatment landscape for and outcomes in HR-positive, HER2-negative metastatic breast cancer (mBC) (0:00)
Trastuzumab deruxtecan for HER2-low and HER2-ultralow mBC (7:49)
Sacituzumab govitecan for HR-positive, HER2-negative mBC (20:44)
Datopotamab deruxtecan for HR-positive, HER2-negative mBC (27:29)
Novel antibody-drug conjugates under investigation for HR-positive mBC (33:19)

CME information and select publications

Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting Jul 24, 2025

Show notes

Featuring perspectives from Dr Rashmi Chugh and Dr Mrinal Gounder, including the following topics:

Introduction: Current Role of General Medical Oncologists in the Treatment of Soft Tissue Sarcomas (STS) (0:00)
Incorporation of Novel Agents and Strategies into the Management of STS — Faculty Presentation (6:38)
Incorporation of Novel Agents and Strategies into the Management of STS — Survey Questions (20:34)
Evolving Treatment Paradigm for Locally Aggressive STS — Faculty Presentation (31:09)
Evolving Treatment Paradigm for Locally Aggressive STS — Survey Questions (46:44)

CME information and select publications

Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting Jul 23, 2025

Show notes

Featuring perspectives from Prof Laurence Albiges and Dr Tian Zhang, including the following topics:

Introduction: Adjuvant Immunotherapy for Localized Renal Cell Carcinoma (RCC) (0:00)
Metastatic Clear Cell RCC — Faculty Presentation (9:22)
Metastatic Clear Cell RCC — Survey Questions (20:24)
Non-Clear Cell RCC — Faculty Presentation (36:02)
Non-Clear Cell RCC — Survey Questions (45:46)
ASCO 2025 (50:12)

CME information and select publications

Chronic Lymphocytic Leukemia — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting Jul 21, 2025

Show notes

Featuring perspectives from Dr Catherine C Coombs and Dr William G Wierda, including the following topics:

Introduction (0:00)
Selection and Sequencing of Therapy for Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) — Dr Wierda (19:25)
First-Line Therapy for CLL — Dr Coombs (44:18)
Novel Agents and Strategies for R/R CLL — Dr Wierda (57:27)

CME information and select publications

Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches Jul 18, 2025

Show notes

Featuring an interview with Ms Jennifer Filipi, including the following topics:

Responsibilities of an oncology nurse and perspectives on the career (0:00)
Case: A woman in her late 70s with BRCA1-mutated ovarian cancer (OC) (3:50)
Case: A woman in her mid 40s, a mother of 3, with advanced OC (27:23)
Case: A woman in her early 70s, a social worker, with platinum-refractory OC (40:02)

NCPD information and select publications

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting Jul 17, 2025

Show notes

Featuring perspectives from Dr Ajay K Nooka and Dr Paul G Richardson, including the following topics:

Introduction: ASCO 2025 Showstoppers (0:00)
Up-Front Treatment of Multiple Myeloma (MM) — Survey Questions (5:50)
Emerging Novel Therapies for Relapsed/Refractory (R/R) MM — Faculty Presentation (11:57)
Emerging Novel Therapies for R/R MM — Survey Questions (26:19)
Current Management of R/R MM — Faculty Presentation (38:34)
Current Management of R/R MM — Survey Questions (49:20)

CME information and select publications

Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates Jul 16, 2025

Show notes

Featuring perspectives from Prof Marina Chiara Garassino, Dr John V Heymach, Prof Solange Peters and Dr Jacob Sands, moderated by Dr Sands, including the following topics:

Introduction (0:00)
Role of Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer (NSCLC) without a Targetable Tumor Mutation — Prof Peters (2:07)
Targeted and Other Novel Therapeutic Strategies for Relapsed Metastatic NSCLC — Prof Garassino (26:30)
Potential Role of TROP2-Targeted Antibody-Drug Conjugates in Advanced NSCLC — Dr Sands (50:19)
Evolving Role of Immune Checkpoint Inhibitors in the Care of Patients with Nonmetastatic NSCLC — Dr Heymach (1:12:36)

CME information and select publications

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting Jul 14, 2025

Show notes

Featuring perspectives from Dr Haley Ellis, Dr Sara Lonardi and Dr Kanwal Raghav, moderated by Dr Christopher Lieu, including the following topics:

Introduction (0:00)
Gastroesophageal Cancers — Dr Lonardi (1:54)
Biliary Tract Cancers — Dr Ellis (39:20)
Colorectal Cancer — Dr Raghav (1:07:10)

CME information and select publications

For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress Jul 11, 2025

Show notes

Featuring perspectives from Dr Jacqueline Broadway-Duren, Dr Bita Fakhri, Ms Corinne Hoffman and Dr Jeff Sharman, including the following topics:

Introduction: Key Factors in the Management of Chronic Lymphocytic Leukemia (CLL) (0:00)
Role of Covalent Bruton Tyrosine Kinase (BTK) Inhibitors for Newly Diagnosed CLL (12:02)
Role of Time-Limited Up-Front Treatment, Including Therapy Combining BTK Inhibitors and Venetoclax, for Newly Diagnosed CLL (37:55)
Role of Pirtobrutinib for Relapsed/Refractory (R/R) CLL (1:02:07)
CAR (Chimeric Antigen Receptor) T-Cell Therapy for R/R CLL (1:16:48)

NCPD information and select publications

Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting Jul 10, 2025

Show notes

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Prof Thomas Powles, moderated by Dr Galsky, including the following topics:

Introduction (0:00)
Current and Future Management of Muscle-Invasive Bladder Cancer — Prof Powles (1:14)
Novel Intravesical Therapies Under Evaluation for Nonmetastatic Urothelial Bladder Cancer (UBC) — Prof Necchi (24:48)
Selection and Sequencing of Therapy for Metastatic UBC — Dr Galsky (44:52)

CME information and select publications

Our TOPPODCAST Picks

Follow Us

Stay Connected

Research To Practice | Oncology Videos

Related Podcasts

Links

Stay Connected